MRYT PHARMA PLC— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019
12 Sep 2019
Small Cap Feast
Ovoca Bio Plc (OVB:LON), 0.6 | Focusrite PLC (TUNE:LON), 310 | Aggregated Micro Power (AMPH:LON), 0 | Diversified Energy Company PLC (DEC:LON), 1,079 | Agronomics Limited (ANIC:LON), 7.9 | UK Oil & Gas Plc (UKOG:LON), 0.0 | Biome Technologies PLC (BIOM:LON), 100 | Barryroe Offshore Energy PLC (PVDRF:OTC), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Feast
Ovoca Bio Plc (OVB:LON), 0.6 | Focusrite PLC (TUNE:LON), 310 | Aggregated Micro Power (AMPH:LON), 0 | Diversified Energy Company PLC (DEC:LON), 1,079 | Agronomics Limited (ANIC:LON), 7.9 | UK Oil & Gas Plc (UKOG:LON), 0.0 | Biome Technologies PLC (BIOM:LON), 100 | Barryroe Offshore Energy PLC (PVDRF:OTC), 0
- Published:
12 Sep 2019 -
Author:
Derren Nathan - Pages:
MRYT PHARMA PLC— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019